Lista de obras - Peter Gibbs - Dominio Público Uruguay

A critical review of the Glasgow Prognostic Score for colorectal cancer

scientific article published on 01 June 2008

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer

artículo científico publicado en 2014

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

artículo científico

APER rate has multiple limitations as an indicator of quality in rectal cancer surgery

artículo científico publicado en 2008

Adjuvant chemotherapy use among older patients with stage III colon cancer

scientific article published on 01 June 2010

An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer.

artículo científico publicado en 2012

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion

artículo científico publicado en 2013

Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria

artículo científico

Assessing aneuploidy with repetitive element sequencing

artículo científico publicado en 2020

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

artículo científico publicado en 2012

Author reply: To PMID 22372920.

artículo científico publicado en 2013

BioGrid Australia facilitates collaborative medical and bioinformatics research across hospitals and medical research institutes by linking data from diverse disease and data types

artículo científico publicado en 2011

Blood-based protein biomarker panel for the detection of colorectal cancer

artículo científico publicado en 2015

Cancer classification using the Immunoscore: a worldwide task force

artículo científico publicado en 2012

Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer

artículo científico publicado en 2009

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

artículo científico publicado en 2008

Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?

artículo científico publicado en 2008

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

artículo científico publicado en 2019

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

artículo científico publicado en 2016

Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.

artículo científico publicado en 2013

Colorectal cancer screening: ensuring benefits outweigh the risks

artículo científico publicado en 2008

Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology.

artículo científico publicado en 2010

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

artículo científico publicado en 2010

Comparing oncological outcomes of laparoscopic versus open surgery for colon cancer: Analysis of a large prospective clinical database.

artículo científico publicado en 2015

Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

artículo científico publicado en 2007

Comparison of ECOG/WHO Performance Status and ASA Score as a Measure of Functional Status

artículo científico publicado en 2014

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

artículo científico publicado en 2014

Cytosine methylation profiling of cancer cell lines.

artículo científico publicado en 2008

DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers

artículo científico publicado en 2008

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

artículo científico publicado en 2018

Detection of circulating tumor DNA in early- and late-stage human malignancies

artículo científico publicado en 2014

Developing a national database for metastatic colorectal cancer management: perspectives and challenges.

artículo científico publicado en 2013

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.

artículo científico publicado en 2012

Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives?

artículo científico publicado en 2012

Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.

artículo científico publicado en 2010

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

article by John J. McNeil et al published 18 October 2018 in The New England Journal of Medicine

Effect of Aspirin on Disability-free Survival in the Healthy Elderly

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.

artículo científico publicado en 2008

Financial incentives in cancer care and impact on prescribing practice.

artículo científico publicado en 2013

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer

artículo científico publicado en 2014

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study

artículo científico publicado en 2013

Guesstimates are not good enough for determining what is happening in routine care.

artículo científico publicado en 2010

Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review

scientific article published on 22 April 2020

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.

artículo científico publicado en 2010

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

artículo científico publicado en 2011

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

artículo científico publicado en 2015

Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive data.

artículo científico publicado en 2009

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

artículo científico publicado en 2022

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation

artículo científico publicado en 2014

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

artículo científico publicado en 2011

Linking data from hospital and cancer registry databases: should this be standard practice?

artículo científico publicado en 2009

Lymph node yield following colorectal cancer surgery.

artículo científico publicado en 2010

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

artículo científico publicado en 2009

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer

artículo científico publicado en 2013

Microsatellite instability status is critical to analysis of survival in stage II colon cancer

artículo científico publicado en 2012

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

artículo científico publicado en 2014

Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer

artículo científico publicado en 2011

Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation

artículo científico publicado en 2011

Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.

artículo científico publicado en 2007

Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?

artículo científico

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

artículo científico

PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.

artículo científico publicado en 2011

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer

artículo científico publicado en 2013

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

artículo científico publicado en 2013

Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes

artículo científico publicado en 2009

Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.

artículo científico publicado en 2013

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

artículo científico publicado en 2012

Predictors of clinic non-attendance: opportunities to improve patient outcomes in colorectal cancer

artículo científico publicado en 2010

Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data

artículo científico publicado en 2012

Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.

artículo científico publicado en 2015

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

scientific article published on 09 May 2019

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial

artículo científico publicado en 2009

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

artículo científico publicado en 2017

Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer

scientific article published on 22 April 2011

Re: Residual treatment disparities after oncology referral for rectal cancer

artículo científico publicado en 2008

Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13

artículo científico publicado en 2011

Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".

artículo científico publicado en 2009

Risk-adjusted pathologic margin positivity rate: a problematic quality indicator

artículo científico publicado en 2015

SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer

artículo científico publicado en 2013

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX s

artículo científico publicado en 2014

Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors

artículo científico publicado en 2014

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

scientific article published on 17 August 2020

Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.

artículo científico publicado en 2008

Surgical oncology issues in locally advanced rectal cancer.

artículo científico publicado en 2011

Surveillance following treatment for colorectal cancer in Australia. Has best practice been adopted by medical oncologists?

artículo científico publicado en 2008

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations

artículo científico publicado en 2013

Survival, mortality and morbidity outcomes after oesophagogastric cancer surgery in New South Wales, 2001-2008

artículo científico publicado en 2014

The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations

scientific article published on 24 January 2019

The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

artículo científico publicado en 2014

Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.

artículo científico publicado en 2014

Towards establishing a national colorectal cancer database: lessons learnt from Bio21 molecular medicine informatics model

artículo científico publicado en 2008

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

artículo científico publicado en 2014

Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice.

artículo científico publicado en 2014

Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice

artículo científico publicado en 2015

Treatment with unfunded drugs in oncology: the impact of access programmes and clinical trials ⬇️

artículo científico publicado el 1 de enero de 2013

Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.

artículo científico publicado en 2011

Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?

artículo científico publicado en 2007

Lista de obras de Peter Gibbs

A critical review of the Glasgow Prognostic Score for colorectal cancer

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

APER rate has multiple limitations as an indicator of quality in rectal cancer surgery

Adjuvant chemotherapy use among older patients with stage III colon cancer

An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer.

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion

Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria

Assessing aneuploidy with repetitive element sequencing

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

Author reply: To PMID 22372920.

BioGrid Australia facilitates collaborative medical and bioinformatics research across hospitals and medical research institutes by linking data from diverse disease and data types

Blood-based protein biomarker panel for the detection of colorectal cancer

Cancer classification using the Immunoscore: a worldwide task force

Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.

Colorectal cancer screening: ensuring benefits outweigh the risks

Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology.

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

Comparing oncological outcomes of laparoscopic versus open surgery for colon cancer: Analysis of a large prospective clinical database.

Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

Comparison of ECOG/WHO Performance Status and ASA Score as a Measure of Functional Status

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

Cytosine methylation profiling of cancer cell lines.

DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Detection of circulating tumor DNA in early- and late-stage human malignancies

Developing a national database for metastatic colorectal cancer management: perspectives and challenges.

Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.

Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives?

Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

Effect of Aspirin on Disability-free Survival in the Healthy Elderly

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.

Financial incentives in cancer care and impact on prescribing practice.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study

Guesstimates are not good enough for determining what is happening in routine care.

Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

Impact of body mass index on colorectal cancer treatment and outcomes: need for prospective and comprehensive data.

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

Linking data from hospital and cancer registry databases: should this be standard practice?

Lymph node yield following colorectal cancer surgery.

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer

Microsatellite instability status is critical to analysis of survival in stage II colon cancer

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer

Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation

Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.

Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis.

PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Patient comorbidities and behaviour once diagnosed are major contributors to disparities in cancer health outcomes

Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

Predictors of clinic non-attendance: opportunities to improve patient outcomes in colorectal cancer

Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data

Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer

Re: Residual treatment disparities after oncology referral for rectal cancer

Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13

Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".

Risk-adjusted pathologic margin positivity rate: a problematic quality indicator

SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer